Developing Recombinant Anti Idiotypic Antibodies for PK/PD and Immunogenicity Assays
![](https://i.ytimg.com/vi/CSvFHKibfH8/mqdefault.jpg)
30:59
How To Improve Your Antibody Drug Development Assays with Anti-Idiotypic Antibodies
![](https://i.ytimg.com/vi/44p08uCyGFk/mqdefault.jpg)
53:56
Webinar - Managing Challenging Bioanalysis for PK/PD assessments for Phase I Biologic
![](https://i.ytimg.com/vi/_E4_Db-g1N8/mqdefault.jpg)
17:38
SIMPLE How do Anti-Drug Antibody Assays work?
![](https://i.ytimg.com/vi/lGysfm8-n7w/mqdefault.jpg)
39:56
Anti Idiotypic Antibodies – A Powerful Tool for Antibody Drug Studies
![](https://i.ytimg.com/vi/KjoyzaMyKUU/mqdefault.jpg)
3:35:15
Pharmacodynamic Biomarkers for Biosimilar Development and Approval: Day 1
![](https://i.ytimg.com/vi/Qpt7AEHPEb8/mqdefault.jpg)
16:41
Working with CAR T cells – from basic research to clinical manufacturing [WEBINAR]
![](https://i.ytimg.com/vi/paO_pjvcCiA/mqdefault.jpg)
46:41
FDA EMA immunogenicity guidelines APR2020
![](https://i.ytimg.com/vi/JZgzY7rL6_c/mqdefault.jpg)
37:20